Literature DB >> 3167228

Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model.

C K Osborne1, C R Ross, E B Coronado, S A Fuqua, L J Kitten.   

Abstract

Estrogen receptor (ER)-negative MDA-231 human breast cancer cells have been shown to secrete high concentrations of several growth factors including transforming growth factor-alpha and insulin-like growth factor I, which could have important autocrine or paracrine growth regulatory functions and, additionally, could explain the rapid autonomous growth of these cells. In contrast, the hormone-responsive, ER-positive MCF-7 cells secrete low levels of these factors constitutively. Since estrogen treatment increases secretion of these growth factors in MCF-7 cells, it has been postulated that these growth factors mediate estrogen's growth effects through an autocrine mechanism. To test this hypothesis we reasoned that growth factors supplied by MDA-231 cells should support growth of MCF-7 cells in an estrogen-depleted environment. Inoculation of castrated female athymic nude mice with MDA-231 cells resulted in rapid tumor growth. However, MDA-231 tumors did not support growth of MCF-7 cells inoculated on the opposite flank by an endocrine mechanism; MCF-7 tumors required estrogen supplementation for growth. To determine if MDA-231 cells could support MCF-7 growth by a paracrine mechanism, various mixtures of the two cell lines were coinoculated at the same site in castrated or in estrogen-supplemented mice. ER was not detectable in tumors derived from a mixed inoculum, indicating the absence of MCF-7 cell growth. Furthermore, DNA flow cytometry of these tumors revealed only a single G1 peak representative of MDA-231 cells in estrogen-deprived mice.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3167228     DOI: 10.1007/bf01807279

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  30 in total

1.  In vitro model systems for the study of hormone-dependent human breast cancer.

Authors:  M E Lippman; C K Osborne; R Knazek; N Young
Journal:  N Engl J Med       Date:  1977-01-20       Impact factor: 91.245

2.  Double labelling assay system for oestrogen and progesterone receptors.

Authors:  H J Grill; B Manz; K Pollow
Journal:  Lancet       Date:  1982-03-20       Impact factor: 79.321

3.  Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture.

Authors:  R W Furlanetto; J N DiCarlo
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

4.  Identification of estrogen-inducible growth factors (estromedins) for rat and human mammary tumor cells in culture.

Authors:  T Ikeda; Q F Liu; D Danielpour; J B Officer; M Iio; F E Leland; D A Sirbasku
Journal:  In Vitro       Date:  1982-12

5.  Human breast cancer cells synthesize and secrete an EGF-like immunoreactive factor in culture.

Authors:  K Mori; M Kurobe; S Furukawa; K Kubo; K Hayashi
Journal:  Biochem Biophys Res Commun       Date:  1986-04-14       Impact factor: 3.575

6.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

7.  Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene.

Authors:  R B Dickson; A Kasid; K K Huff; S E Bates; C Knabbe; D Bronzert; E P Gelmann; M E Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

8.  Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors.

Authors:  R Derynck; D V Goeddel; A Ullrich; J U Gutterman; R D Williams; T S Bringman; W H Berger
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

9.  Correlation of primary breast cancer histopathology and estrogen receptor content.

Authors:  E R Fisher; C K Osborne; W L McGuire; C Redmond; W A Knight; B Fisher; G Bannayan; A Walder; E J Gregory; A Jacobsen; D M Queen; D E Bennett; H C Ford
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

10.  Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity.

Authors:  A Kasid; M E Lippman; A G Papageorge; D R Lowy; E P Gelmann
Journal:  Science       Date:  1985-05-10       Impact factor: 47.728

View more
  5 in total

1.  Fibroblast function in paracrine interactions between breast cancer tissue and its stromal elements.

Authors:  A A Hakim
Journal:  Naturwissenschaften       Date:  1989-07

Review 2.  Autocrine and paracrine growth regulation of breast cancer: clinical implications.

Authors:  C K Osborne; C L Arteaga
Journal:  Breast Cancer Res Treat       Date:  1990-01       Impact factor: 4.872

3.  Paracrine interaction in co-culture of hormone-dependent and independent breast cancer cells.

Authors:  V Cappelletti; C Ruedl; P Miodini; L Fioravanti; D Coradini; G Di Fronzo; R Silvestrini
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

4.  Gene expression in oestrogen-dependent human breast cancer xenograft tumours.

Authors:  A M Thompson; C M Steel; M E Foster; D Kerr; D Paterson; D Deane; R A Hawkins; D C Carter; H J Evans
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

5.  Effects of hormones on tumor growth and immunoreactive insulin-like growth factor-1 of estrogen receptor-positive human breast cancer (MCF-7) transplanted in nude mice.

Authors:  M Noguchi; N Koyasaki; I Miyazaki; Y Mizukami
Journal:  Jpn J Cancer Res       Date:  1991-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.